Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis

PLoS ONE ◽

10.1371/journal.pone.0203058 ◽

2018 ◽

Vol 13 (8) ◽

pp. e0203058 ◽

Author(s):

Friedemann Schad ◽

Anja Thronicke ◽

Megan L. Steele ◽

Antje Merkle ◽

Burkhard Matthes ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Stage Iv ◽

Viscum Album ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Multicenter Analysis

Download Full-text

PRS66 REAL-WORLD PROGRESSION-FREE AND OVERALL SURVIVAL OF ADVANCED NON-SMALL-CELL LUNG CANCER PATIENTS: ANALYSIS BASED ON A NEW GERMAN EMR DATASET

Value in Health ◽

10.1016/j.jval.2019.09.2555 ◽

2019 ◽

Vol 22 ◽

pp. S884

Author(s):

T. Wilke ◽

A. Dittmar ◽

S. Mueller ◽

H. Juhl

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Mature progression-free survival (PFS) milestones in real world stage IV, non-squamous, non-small cell lung cancer patients (nsqNSCLC) treated with first line pemetrexed(Pem)/platinum(Plat) +/- bevacizumab(Bev) followed by pem +/-bev maintenance.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e21063 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e21063-e21063

Author(s):

Parva Kiran Bhatt ◽

Philip D. Bonomi ◽

Sanjib Basu ◽

Mary J. Fidler ◽

Marta Batus

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Stage Iv ◽

Progression Free Survival ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text

WITHDRAWN: EGFR exon 19 deletion is associated with favorable overall survival after first-line icotinib therapy in advanced non-small cell lung cancer patients: a retrospective, multiple-center, real-world study

10.18632/oncotarget.23720 ◽

2017 ◽

Vol 0 (0) ◽

Author(s):

Chuantao Zhang ◽

Helei Hou ◽

Xin Cheng ◽

Dianxia Gong ◽

Ling Yang ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Exon 19 Deletion ◽

Download Full-text

OA23.06 Overall Survival (OS) of EGFR Mutation Positive Non-Small Cell Lung Cancer Patients: Real-World Treatment Patterns of 1,660 Japanese Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.364 ◽

2017 ◽

Vol 12 (1) ◽

pp. S336-S337

Author(s):

Kazushi Yoshida ◽

Yuichiro Ohe ◽

Akira Inoue ◽

Toru Kumagai ◽

Masayuki Takeda ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Egfr Mutation ◽

Japanese Patients ◽

Treatment Patterns ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation

OncoImmunology ◽

10.1080/2162402x.2020.1865670 ◽

2021 ◽

Vol 10 (1) ◽

pp. 1865670

Author(s):

Wei Nie ◽

Lu Gan ◽

Xin Wang ◽

Kai Gu ◽

Fang-Fei Qian ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Is Overall Survival in Non-Small Cell Lung Cancer Patients Treated With Definitive Radiation Therapy Affected by Dose to the Heart?

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.1799 ◽

2016 ◽

Vol 96 (2) ◽

pp. E465-E466

Author(s):

T. Schytte ◽

T.B. Nielsen ◽

C. Brink ◽

O. Hansen

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Real‐World Utilization of EGFR TKIs and Prognostic Factors for Survival in EGFR‐Mutated Non‐Small Cell Lung Cancer Patients with Brain Metastases

International Journal of Cancer ◽

10.1002/ijc.33677 ◽

2021 ◽

Author(s):

Xiaoqing Yu ◽

Jiamin Sheng ◽

Guoqiang Pan ◽

Yun Fan

Keyword(s):

Lung Cancer ◽

Prognostic Factors ◽

Brain Metastases ◽

Cancer Patients ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated ◽

Download Full-text

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone

Annals of Oncology ◽

10.1093/annonc/mdm061 ◽

2007 ◽

Vol 18 (5) ◽

pp. 903-908 ◽

Author(s):

S. Novello ◽

P. Bruzzi ◽

C. Barone ◽

R. Buosi ◽

A. Masotti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Stage Iv ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis

Journal of Experimental & Clinical Cancer Research ◽

10.1186/1756-9966-32-45 ◽

2013 ◽

Vol 32 (1) ◽

pp. 45 ◽

Author(s):

Yunzhen Chen ◽

Haichun Liu ◽

Wenliang Wu ◽

Yi Li ◽

Jianmin Li

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Bone Metastasis ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Genetic Variants ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Pyrotinib in HER2 Heterogeneously Mutated or Amplified Advanced Non-small Cell Lung Cancer Patients: A Retrospective Real-world Study (PEARL)

Journal of the National Cancer Center ◽

10.1016/j.jncc.2021.08.001 ◽

2021 ◽

Author(s):

Guangjian Yang ◽

Xuezhi Hao ◽

Jiaqi Hu ◽

Keke Dong ◽

Haiyan Xu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text